FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.”
The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.
NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State